TRUMBULL, CT--(Marketwired - May 5, 2015) - ZetrOZ Inc. is pleased to announce today that its ultrasound device for pain, sam®, has been selected as a finalist in the Rehabilitation and Assistive Technology Products Category of the 18th Annual Medical Design Excellence Awards competition. This year, 45 exceptional finalists in 10 medical technology product categories were selected and officially announced in the May Issue of MD+DI (Medical Device and Diagnostic Industry) magazine. Winners will be awarded at the 2015 MDEA Ceremony Tuesday, June 9, 2015 in conjunction with the MD&M East event at the Jacob K. Javits Convention Center in New York.
ZetrOZ, Inc. developed the world's only multi-hour wearable ultrasound device, sam®, for pain relief which, when combined with traditional PT, speeds resolution of many musculoskeletal conditions and tendinopathies as well as treating pain associated with OA.
Led by Co-Founder and Chief Science & Technology Officer George K. Lewis, Jr., Ph.D., Co-Founder and CEO Bryant Guffey and, Co-Founder and COO JoAnne Guarino, ZetrOZ produces innovative technology that has been classified and cleared in a new FDA category of ultrasound bio-electronics and CE-marked in Europe last year.
"Recognition such as this helps propel new technology like sam into the medical mainstream, making it easier for the millions of pain sufferers around the world to experience easy-to-use, drug-free relief," says Dr. Lewis. "We've received positive feedback from patients and medical professionals alike since introducing sam a year ago, and being shortlisted for the MDEA this year marks another concrete milestone for our team."
About ZetrOZ, Inc.
ZetrOZ is revolutionizing the medical therapeutic industry with its proprietary technology including the recently introduced sam® sustained acoustic medicine www.samrecover.com and UltrOZ® www.ultroz.com, miniature wearable ultrasound devices for accelerated recovery and pain management. The innovative non-invasive therapeutic technologies have been shown to be more efficient, more portable, and more economically viable than any ultrasound systems presently available and are currently the world's smallest and strongest ultrasound therapy systems. The sam® device addresses the growing demand for non-pharmaceutical and bio-regenerative alternatives to typical pharma-based pain treatments in the approximately $62 billion U.S. pain management market. Early adopters of sam® include physical therapists, athletic trainers and athletes for improved recovery of overuse injuries such as tendinopathies and muscle strains. For more information, visit www.zetroz.com.
About the Medical Design Excellence Awards
The Medical Design Excellence Awards are presented by UBM Canon, the global advanced manufacturing and medtech authority, and by Medical Device and Diagnostic Industry (MD+DI), the industry's central source for late breaking news, information, and business intelligence. MDEA entries are judged by an impartial panel of medtech experts comprised of practicing doctors, nurses, and technicians alongside industrial designers, engineers, manufacturers, and human factors experts. MDEA jurors review entries based on the following criteria: the ability to overcome all challenges so the product meets its clinical objectives; innovative use of materials, components, and processes; user-related functions improving healthcare delivery and changing traditional medical attitudes or practices; features providing enhanced benefits to the patient in relation to clinical efficacy; manufacturing cost-effectiveness and profitability; and healthcare system benefits. The 2015 Medical Design Excellence Awards are sponsored by: K-Tube Technologies; Medical Packaging Community; Phillips-Medisize; Proto Labs; Stellar Technologies; and Teleflex Medical OEM. Visit www.MDEAwards.com for more info or e-mail mdea@ubm.com.
Contact Information:
Media Contact:
Eri Mizobe
Account Executive, Crenshaw Communications
eri@crenshawcomm.com
212-367-9744